Interest in biosimilar protein drugs continues to grow, and pharmaceutical manufacturers are racing to patent new drug formulations in order to survive in an evolving market.
Become a subscriber to read this story, as well as other exclusive articles and interviews. The process is entirely free and takes no time at all.